Myasthenia gravis is a rare autoimmune disorder that affects the muscles and nerves responsible for controlling voluntary muscle movements. Late-onset myasthenia gravis is a subtype of the condition that typically develops after age 50.
The symptoms of myasthenia gravis can vary, but they typically include muscle weakness and fatigue that worsens with activity and improves with rest. Commonly affected muscles include those that control eye movements, facial expressions, swallowing, and breathing. Other symptoms may include drooping eyelids, double vision, difficulty speaking, and difficulty chewing or swallowing.
The exact cause of myasthenia gravis is unknown, but research suggests that genetics may play a role in its development. Studies have shown that individuals with a family history of the condition are more likely to develop it. Certain genes have also been identified as increasing the risk of developing myasthenia gravis.
Myasthenia gravis is most commonly diagnosed in young women (20s and 30s) but can affect men and women of any age. Late-onset myasthenia gravis may occur after the age of 60.
Seek medical attention for muscle weakness, particularly in the muscles responsible for breathing and swallowing. Early diagnosis and treatment can help manage symptoms and prevent complications. Especially if you have a family history of myasthenia gravis, be aware of the signs and talk to your doctor as soon as any arise.
In conclusion, late-onset myasthenia gravis is a rare autoimmune disorder affecting the control of the body’s voluntary muscles, especially those of the face and respiratory system. While the exact cause is unknown, genetics may play a role in its development. Early recognition and prompt treatment can help manage symptoms and prevent complications - find out your genetic predisposition today!
Interested in trying the BioCertica DNA Autoimmune kit? Click here and add Autoimmune Diseases to your cart for only R1699.
If you own any other BioCertica DNA kit, you can instantly unlock your Autoimmune Disease results for only R659* in-app.
*Terms and conditions apply: Pharmacogenetics results are R1999 in-app.